Hadd, Michael J.,Hocker, Michael D.,Holladay, Mark W.,Liu, Gang,Rowbottom, Martin W.,Xu, Shimin
申请号：
HRP20160744
公开号：
HRP20160744T2
申请日:
2016.06.07
申请国别(地区):
HR
年份:
2017
代理人:
摘要：
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFR&bgr； kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
